Kidney 11β-HSD2 Is Inhibited by Glycyrrhetinic Acid-Like Factors in Human Urine
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 29 (1) , 500-505
Abstract
We have previously shown that human urine contains substances that, like glycyrrhetinic acid, inhibit 11β-HSD1. We have named these substances “glycyrrhetinic acid-like factors” or GALFs. We now have found that human urine contains measurable quantities of both 11β(HSD1)- and 11β(HSD2)-GALF inhibitory substances. Both are markedly elevated in pregnancy. Their chemical and high-performance liquid chromatography (HPLC) characteristics suggest that several of the GALFs are steroidal. Large quantities of neutral 11β(HSD1)- and 11β(HSD2)-GALFs can be extracted directly from urine into ethyl acetate, yielding fraction EA 1 . Hydrolysis of the GALFs remaining in the aqueous phase by β-glucuronidase markedly increases the total amounts of GALFs, with the majority now being ethyl acetate extractable (fraction EA 2 ). These EA 2 posthydrolysis GALFs can be separated by HPLC resulting in at least six components with inhibitory activity against each isoenzyme. Only two GALF peaks are active against both 11β-HSD1 and 11β-HSD2. The others are peaks with specific 11β(HSD 1)- and 11β(HSD2)-GALF inhibitory activity. The GALFs in the same posthydrolysis EA 2 extract are also inhibitory toward the 11β-HSD1 that is present in vascular smooth muscle where they may play a role in the mechanisms controlling blood pressure. We have also found that 11β-HSD2 is selectively inhibited by 5α-(but not by 5β-) reduced steroids. GC-MS analysis of the 11β(HSD2)-GALFs in EA 2 is now being performed to determine whether this group includes 3α,5α-ring A-tetrahydro-reduced derivatives of steroids.Keywords
This publication has 15 references indexed in Scilit:
- Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenaseNature Genetics, 1995
- 11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat.Endocrinology, 1995
- Protein kinase C and insulin receptor β-subunit serine phosphorylation in cultured foetal rat hepatocytesMolecular and Cellular Endocrinology, 1994
- Possible endogeneous regulators of steroid inactivating enzymes and glucocorticoid-induced Na+ retentionSteroids, 1994
- 11β-Hydroxysteroid Dehydrogenase1993
- Detection of glycyrrhetinic acid-like factors (GALFs) in human urine.Hypertension, 1992
- The “Mineralocorticoid-Like” Actions Conferred on Corticosterone by Carbenoxolone Are Inhibited by the Mineralocorticoid Receptor (Type I) Antagonist RU28318*Endocrinology, 1991
- llβ-Hydroxysteroid Dehydrogenase Activity in the Renal Target Cells of Aldosterone*Endocrinology, 1991
- Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, MediatedScience, 1988
- LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTORThe Lancet, 1988